Shuaizhen Zhou

Dr. Shuaizhen Zhou


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2025 in The Plant Cell
Verified
Journal Article
Closed access
JDJia Dong
Jia Dong
SCSeth W Croslow
Seth W Croslow
SLStephan T Lane
Stephan T Lane
DCDaniel C Castro
Daniel C Castro
JBJantana Blanford
Jantana Blanford
MHMatthew E Hudson
Matthew E Hudson
Plant bioengineering is a time-consuming and labor-intensive process with no guarantee of achieving desired traits. Here, we present a fast, automated, scalable, high-throughput pipeline for plant bioengineering (FAST-PB) in maize (Zea mays) and Nicotiana benthamiana. FAST-PB enables genome editing and product characterization by integrating automated biofoundry engineering of callus and protoplast cells with single-cell matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). We first demonstrated that FAST-PB could streamline Golden Gate cloning, with the capacity to construct 96 vectors in parallel. Using FAST-PB in protoplasts, we found that PEG2050 increased transfection efficiency by over 45%. For proof-of-concept, we established a reporter-gene-free method for CRISPR editing and phenotyping via mutation of high chlorophyll fluorescence 136. We show that diverse lipids were enhanced up to 6-fold using CRISPR activation of lipid controlling genes. In callus cells, an automated transformation platform was employed to regenerate plants with enhanced lipid traits through introducing multigene cassettes. Lastly, FAST-PB enabled high-throughput single-cell lipid profiling by integrating MALDI-MS with the biofoundry, protoplast, and callus cells, differentiating engineered and unengineered cells using single-cell lipidomics. These innovations massively increase the throughput of synthetic biology, genome editing, and metabolic engineering and change what is possible using single-cell metabolomics in plants.

15 February 2023 in Analytical Chemistry
Verified
Journal Article
Closed access
SZShuaizhen Zhou
Shuaizhen Zhou
ZFZia Fatma
Zia Fatma
PXPu Xue
Pu Xue
SMShekhar Mishra
Shekhar Mishra
Mingfeng CaoMingfeng Cao
Mingfeng Cao
JSJonathan Sweedler
Jonathan Sweedler

5 February 2024 in ChemBioChem
Verified
Journal Article
Open access
YZYu Zhou
Yu Zhou
SZShuaizhen Zhou
Shuaizhen Zhou
SLScott Lyons
Scott Lyons
HSHaoran Sun
Haoran Sun
JSJonathan Sweedler
Jonathan Sweedler
YLYi Lu
Yi Lu
Engineering efficient biocatalysts is essential for metabolic engineering to produce valuable bioproducts from renewable resources. However, due to the complexity of cellular metabolic networks, it is challenging to translate success in vitro into high performance in cells. To meet such a challenge, an accurate and efficient quantification method is necessary to screen a large set of mutants from complex cell culture and a careful correlation between the catalysis parameters in vitro and performance in cells is required. In this study, we employed a mass‐spectrometry based high‐throughput quantitative method to screen new mutants of 2‐pyrone synthase (2PS) for triacetic acid lactone (TAL) biosynthesis through directed evolution in E. coli. From the process, we discovered two mutants with the highest improvement (46 fold) in titer and the fastest kcat (44 fold) over the wild type 2PS, respectively, among those reported in the literature. A careful examination of the correlation between intracellular substrate concentration, Michaelis‐Menten parameters and TAL titer for these two mutants reveals that a fast reaction rate under limiting intracellular substrate concentrations is important for in‐cell biocatalysis. Such properties can be tuned by protein engineering and synthetic biology to adopt these engineered proteins for the maximum activities in different intracellular environments.

17 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SZShuaizhen Zhou
Shuaizhen Zhou
RGRuolin Geng
Ruolin Geng
CKChang-Qiang Ke
Chang-Qiang Ke
FGFan Ge
Fan Ge
YCYing Chen
Ying Chen
YYYE YANG
YE YANG
A comprehensive phytochemical investigation of the whole plant of Stemona parviflora led to the isolation of 13 alkaloidal constituents, including five new alkaloids: 13α-hydroxyparvistemonine (1), 12α-methoxyparvistemonine (2), parvistemonine-N-oxide (3), parvistemoninine (4), and parvistemofoline (5). The structures of these compounds were elucidated through extensive analyses of 1D and 2D NMR spectra, DFT NMR calculation, and comparisons with data in literature. Notably, compounds 1-4 represent new examples of the rare parvistemoline-type alkaloids, with compound 4 showcasing a unique rearranged skeleton. Additionally, parvistemofoline (5) was identified as a distinct alkaloid skeleton characterized by a n-butyl side chain. These findings significantly expand our understanding of the chemical diversity of parvistemoline-type alkaloids, and provide clues for elucidating the biosynthetic pathways of these structurally unique parvistemoline alkaloids.

13 January 2025 in Chemistry
Verified
Journal Article
Open access
PDF file
SZShuaizhen Zhou
Shuaizhen Zhou
RGRuolin Geng
Ruolin Geng
CKChangqiang Ke
Changqiang Ke
FGFan Ge
Fan Ge
YCYing Chen
Ying Chen
YYYE YANG
YE YANG
A comprehensive phytochemical investigation of the whole plant of Stemona parviflora led to the isolation of 13 alkaloidal constituents, including five new alkaloids, parvistemonines B–F (1–5). The structures of these compounds were elucidated through extensive analyses of 1D and 2D NMR spectra, DFT NMR calculation, and comparisons with data in the literature. Notably, compounds 1–4 represent new examples of the rare parvistemoline-type alkaloids, with compound 4 showcasing a unique rearranged skeleton. Additionally, parvistemonine F (5) was identified as a distinct alkaloid skeleton characterized by a n-butyl side chain. These findings significantly expand our understanding of the chemical diversity of parvistemoline-type alkaloids and provide clues for elucidating the biosynthetic pathways of these structurally unique parvistemoline alkaloids.

31 July 2026 in Animals
Verified
Journal Article
Open access
PDF file
ZXZhang Xiaorui
Zhang Xiaorui
WSWenli Shi
Wenli Shi
XYXinlin Yang
Xinlin Yang
YLYuchen Lin
Yuchen Lin
BYBo Yang
Bo Yang
SZShuaizhen Zhou
Shuaizhen Zhou
Resveratrol (RES) is a natural polyphenolic compound characterized by poor aqueous solubility and significant first-pass metabolism, resulting in extremely low oral bioavailability. Although resveratrol-loaded nanostructured lipid carriers (RES-NLCs) have shown potential in enhancing oral absorption, direct experimental evidence for their intestinal lymphatic transport mechanism remains limited, and existing explanations is largely based on indirect inference. RES-NLCs were prepared, and their pharmacokinetics and lymphatic transport characteristics were evaluated using a laboratory-established mesenteric lymph duct–jugular vein assisted reflux model in rats. Simultaneously, a 28-day repeated-dose toxicity study was conducted in ICR mice. Pharmacokinetic results showed that compared with RES-Sol, RES-NLCs increased Cmax by approximately 2.3-fold, improved relative bioavailability by 7-fold, and achieved an absolute bioavailability of 176%. The lymphatic transport model confirmed that RES-NLCs are absorbed via the intestinal lymphatic pathway. In the 28-day repeated-dose toxicity study, no mortality or obvious clinical symptoms were observed at a dose of 10 mg/kg. The RES-NLCs group exhibited increased liver coefficient and decreased spleen coefficient. Hematological analysis showed a mild increase in red blood cell count, along with decreases in mean corpuscular volume and red blood cell distribution width coefficient of variation. Serum biochemistry revealed significant elevations in aspartate aminotransferase and alanine aminotransferase (p = 9 × 10−5 and p = 4.02 × 10−7, respectively). However, no significant differences were observed in the organ coefficients of the heart, lungs, kidneys, or brain. Body composition and magnetic resonance imaging showed no abnormalities, and histopathological examination of major organs including the liver, stomach, and intestines revealed no structural damage. These findings provide direct evidence that RES-NLCs enhance the oral bioavailability by promoting intestinal lymphatic uptake, suggesting that this system may serve as an effective delivery platform for poorly soluble hydrophobic drugs.